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Background: New neurons are generated throughout adulthood in the olfactory bulb and dentate 
gyrus of the hippocampus, and are incorporated into hippocampal networks during maintenance 
of neural circuits and in turn contribute to learning and memory. Numerous intrinsic and 
extrinsic factors such as growth factors, transcription factors, and cell cycle regulators control 
neural stem cells proliferation, differentiation, and maintenance into mature neurons. However, 
the genetic mechanisms controlling adult hippocampal neurogenesis remain unclear. We 
performed a gene-based association analysis of neurogenesis pathway-related candidate genes 
using data from the Alzheimer's Disease Neuroimaging Initiative (ADNI). 
Methods: Neurogenesis-related genes were curated from existing databases (Qiagen RT2 Profiler 
PCR Arrays, GoGene and MANGO). The gene list was filtered by AD susceptibility genes from 
the Alzgene database (http://www.alzgene.org/) and large-scale GWAS (Lambert,et al. 2013, 
Nature). Caucasian non-Hispanic individuals (N=1,525) with AD or mild cognitive impairment 
(MCI) and cognitively normal older adults from the ADNI cohort with MRI and genotyping data 
were included. Gene-based association analysis of neurogenesis pathway-related candidate genes 
was performed.  Baseline bilateral hippocampus and hippocampal subfield (CA regions and 
dentate gyrus) volumes were extracted from MRI and served as phenotypes. Gender, age, 
intracranial volume, MRI field strength, and diagnosis at scanning were entered as covariates. 
The empirical p value from permutation testing for each gene was adjusted for the number of 
significant SNPs in each gene.  
Results: ADORA2A was significantly associated with total hippocampal volume and 
hippocampal subfield volumes (p<0.001). For the most significant SNP (rs9608282) in 
ADORA2A, dosage of the minor allele (T) increased hippocampal volume. rs9608282 was also 
associated with composite memory score (p= 0.0076).  
Conclusion: ADORA2A-mediated control of neuroinflammation modulates adult neurogenesis 
and the inhibition of ADORA2A prevents Aβ-induced neurotoxicity. Targeted pathway-based 
genetic analysis combined with brain imaging endophenotypes appears promising to help 
elucidate disease pathophysiology and identify potential therapeutic targets. 
 
 
**Data used in preparation of this article were obtained from the Alzheimer’s Disease 
Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within 
the ADNI contributed to the design and implementation of ADNI and/or provided data but did not 
participate in analysis or writing of this report. A complete listing of ADNI investigators can be 
found at: http://adni.loni.usc.edu/wp-
content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf 
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